An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
NCT ID: NCT01690455
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
247 participants
OBSERVATIONAL
2011-07-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adequate iron status
* Signed informed consent form
Exclusion Criteria
* Where investigator considers the patient unsuitable for inclusing for other reasons (e.g. severe co-morbidities as active bleeding, infections or cancer)
* Pregnant or lactating female patients
* Any contraindications against treatment with Mircera (according to local Summary of Product Characteristics)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bartoszyce, , Poland
Bydgoszcz, , Poland
Ciechanów, , Poland
Częstochowa, , Poland
Dębica, , Poland
Gliwice, , Poland
Gmina Świecie, , Poland
Gorzów Wielkopolski, , Poland
Grudziądz, , Poland
Hajnówka, , Poland
Jastrzębie Zdrój, , Poland
Jaworzno, , Poland
Kępno, , Poland
Konin, , Poland
Kościerzyna, , Poland
Lodz, , Poland
Milicz, , Poland
Piła, , Poland
Polanica-Zdrój, , Poland
Radom, , Poland
Rybnik, , Poland
Rzeszów, , Poland
Rzeszów, , Poland
Sandomierz, , Poland
Siedlce, , Poland
Starachowice, , Poland
Suwałki, , Poland
Słupsk, , Poland
Warsaw, , Poland
Wołomin, , Poland
Wroclaw, , Poland
Zgorzelec, , Poland
Łapy, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML25701
Identifier Type: -
Identifier Source: org_study_id